|
|
Effects of metabolic syndrome on onset age and long-term outcomes in patients with acute coronary syndrome
|
Jing-jing Xu, Ying Song, Ping Jiang, Lin Jiang, Xue-yan Zhao, Zhan Gao, Jian-xin Li, Shu-bin Qiao, Run-lin Gao, Yue-jin Yang, Yin Zhang, Bo Xu, Jin-qing Yuan
|
|
|
Table 3 Clinical outcomes in patients with early-onset ACS and late-onset ACS during five-year follow-up, n (%)
|
|
Parameters | Hospitalization events | Five-year follow-up events | Early-onset ACS (n=1,558) | Late-onset ACS (n=3,044) | P-value | Early-onset ACS (n=1,558) | Late-onset ACS (n=3,044) | P-value | MACCEs | 18 (1.2) | 51 (1.7) | 0.169 | 262 (16.8) | 662 (21.7) | <0.001* | All-cause death | 2 (0.1) | 6 (0.2) | 0.596 | 24 (1.5) | 117 (3.8) | <0.001* | Cardiac death | 2 (0.1) | 5 (0.2) | 0.768 | 17 (1.1) | 61 (2.0) | 0.023* | Recurrent myocardial infarction | 17 (1.1) | 45 (1.5) | 0.281 | 81 (5.2) | 191 (6.3) | 0.143 | Stent thrombosis | 3 (0.2) | 8 (0.3) | 0.644 | - | - | - | Target vessel revascularization | - | - | - | 195 (12.5) | 392 (12.9) | 0.728 | Recurrent stroke | 0 (0) | 0 (0) | 1.000 | 34 (2.2) | 127 (4.2) | 0.001* | Bleeding (BARC 2 to 5) | 1 (0.1) | 3 (0.1) | 0.708 | 255 (16.4) | 377 (12.4) | <0.001* |
|
|
|